... that there has not been more dot-connecting by institutions and larger investors between Healios and ATHX thus far to move this stock higher. Volume in ATHX has been lower than average for a large number of recent trading sessions, despite the fact that the Japan strategy and Healios investment is public knowledge.
A few thoughts here:
1. We're assuming on this board that Healios' movement is due to ATHX. Might it not be?
2. ATHX still is a micro-cap and is flying below many institutions' radar.
3. Once burned, twice burned, many-times burned investors in bio/stem cell are still wary?
One would have thought the Stanford results would have sent some strapping young research analysts digging in the NASDAQ trenches, but not yet...
Excellent analysis and spot on. I agree that the shorts really want to take this down to get out at a decent level - today's hard drops were all the evidence I needed of that. If we build from here the chart will continue to look very good.